A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
This narrative information graphic contextualizes the lack of current maternal morbidity and mortality data in the United States since the Dobbs v Jackson Women’s Health Organization decision in 2022.
AMA J Ethics. 2024;26(1):E92-93. doi:
10.1001/amajethics.2024.92.
Two bioethicists argue that prenatal disability screening promotes negativity toward the disabled and gives parents the ability to selectively form families.
A philosophy professor argues that prenatal genetic testing allows potentially painful afflictions to be discovered prior to birth and does not unjustly discriminate against disabled people.
Mahesh Krishnamurthy, MD and Michael L. Freedman, MD
Physicians need to be aware of the cautions required with use of low molecular weight heparin and unfractionated heparin and perform a risk-benefit analysis before prescribing them to patients.
Global health training offered through UCSF’s EMPOWUR program prepares ob/gyn residents to work in under-resourced communities locally as well as globally.
AMA J Ethics. 2018;20(3):253-260. doi:
10.1001/journalofethics.2018.20.3.medu1-1803.
Lusine Aghajanova, MD, PhD and Cecilia T. Valdes, MD
While sex selection of children for nonmedical reasons is not prohibited in the United States, the authors believe that sperm sorting should not be used until more safety data are available.